Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Biomarkers
Benefits of MR-proADM-guided decision-making in the emergency department: clinical and economic evaluation in Italy, Germany, Spain, and the UK
Camilla Portaa AdRes-Health Economics and Outcome Research, Turin, ItalyCorrespondence[email protected]
https://orcid.org/0000-0001-8402-6934
https://orcid.org/0000-0001-8402-6934, Hirad Houshmandb DiaSorin SpA, Saluggia, Italyhttps://orcid.org/0000-0001-5208-2499
https://orcid.org/0000-0001-5208-2499, Massimiliano Poveroa AdRes-Health Economics and Outcome Research, Turin, Italyhttps://orcid.org/0000-0003-0666-066X
https://orcid.org/0000-0003-0666-066X, Lorenzo Pradellia AdRes-Health Economics and Outcome Research, Turin, Italyhttps://orcid.org/0000-0002-7648-8917
https://orcid.org/0000-0002-7648-8917, , , Tabea Schuetzec B·R·A·H·M·S GmbH, Thermo Fisher Scientific, Hennigsdorf, Germanyhttps://orcid.org/0000-0001-7630-3794
https://orcid.org/0000-0001-7630-3794, Stefan Kirschc B·R·A·H·M·S GmbH, Thermo Fisher Scientific, Hennigsdorf, Germanyhttps://orcid.org/0009-0003-8978-9852
https://orcid.org/0009-0003-8978-9852 & Juan González del Castillod Emergency Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spainhttps://orcid.org/0000-0002-4329-9802
https://orcid.org/0000-0002-4329-9802 show all